MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Rapid Picture Naming in Parkinson’s Disease Using the Mobile Universal Lexicon Evaluation System (MULES) Test

    J. Conway, C. Gonzalez, S. Fallon, J. Martone, L. Hasanaj, A. Lepor, L. Serrano, J. Rucker, S. Galetta, S. Frucht, L. Balcer (New York, NY, USA)

    Objective: To introduce the Mobile Universal Lexicon Evaluation System (MULES) to the visual assessment of patients with Parkinson’s Disease (PD). Background: The MULES is a…
  • 2019 International Congress

    Do non-motor fluctuations temporarily match ON/OFF motor condition?

    E. Del Prete, E. Schmitt, S. Meoni, V. Fraix, A. Castrioto, P. Pelissier, R. Ceravolo, E. Moro (Grenoble, France)

    Objective: The aim of this study was to explore the relation between non-motor neuropsychological fluctuations, identified with the Neuropsychiatric Fluctuation Scale (NFS), and motor fluctuations…
  • 2019 International Congress

    Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson’s disease

    M. Fabbri, P. Chatkaew, C. Artusi, A. Romagnolo, M. Rizzone, M. Zibetti, L. Lopiano (Turin, Italy)

    Objective: To investigate the long-term effect of levodopa-carbidopa intestinal gel (LCIG) on axial signs in Parkinson's disease (PD) patients and the related prognostic factors. Background:…
  • 2019 International Congress

    Diagnostic accuracy of Progressive Supranuclear Palsy: Experience of a movement disorders center

    M. Gultekin (Kayseri, Turkey)

    Objective: The purpose of this paper is to emphasize the importance of correct diagnosis in PSP. Background: Progressive supranuclear palsy (PSP) is a commonly disease…
  • 2019 International Congress

    Drug Utilization in a Real World Cohort with Progressive Supranuclear Palsy

    G. Hoeglinger, D. Oleske, J. Zamudio, R. Diegidio, J. Holman (Munich, Germany)

    Objective: To evaluate the frequency of prescription medications commonly associated with the management of PSP in the community. Background: Progressive Supranuclear Palsy (PSP) is a…
  • 2019 International Congress

    Vascular Parkinsonism and Parkinson’s Disease: clinical differences concerning balance impairment

    R. Jesus, R. Raimundo, C. Azoia, M. Mendes, V. Espirito-Santo, A. Almeida, I. Rego, AG. Velon (Vila Real, Portugal)

    Objective: Determine and compare lower body predominance and balance between Vascular Parkinsonism (VP) and Parkinson’s Disease (PD)patients in a hospital-based sample. Background: Despite the recognition…
  • 2019 International Congress

    Non-motor symptoms and risk of functional dependency in early Parkinson’s disease

    R. Kim, D. Yoo, JH. Im, HJ. Kim, B. Jeon (Seoul, Republic of Korea)

    Objective: To determine whether non-motor symptoms predict the development of functional dependency in Parkinson’s disease (PD). Background: Non-motor symptoms are increasingly recognized as an integral…
  • 2019 International Congress

    Speculation on the timing of iron deposition in the putamen of patients with multiple system atrophy: multimodal MRI study

    MJ. Lee, JH. Lee (Yangsan-Si, Republic of Korea)

    Objective: We sought to investigate the temporal pattern of iron deposition in  the putamen of patients with multiple system atrophy (MSA)  by calculating conditional probabilities…
  • 2019 International Congress

    Increased vesicular monoamine transporter alleviate MPTP-induced impairment of neurogenesis

    K. Ma, G. Zhang, C. Han, X. Guo, Y. Xia, F. Wan, L. Kou, S. Yin, L. Liu, N. Xiong, J. Huang, T. Wang (Wuhan, China)

    Objective: In this study, we employed vesicular monoamine transporter 2–overexpressing mice (VMAT2-HI) to investigate the influence of increased vesicular storage of catacholamines on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced…
  • 2019 International Congress

    Amimia in Parkinson’s Disease and its Relationship with Motor and Non-Motor Symptoms

    T. Maycas-Cepeda, C. Feliz-Feliz, L. Gomez-Vicente, R. García-Cobos, P. Lopez-Ruiz, R. Arroyo, PJ. García- Ruiz (Pozuelo de Alarcon, Spain)

    Objective: To asses the correlation of amimia (facial bradykinesia) with motor and non-motor symptoms (cognition and depression) in Parkinson´s disease (PD) patients. Background: Reduced facial expression,…
  • « Previous Page
  • 1
  • …
  • 129
  • 130
  • 131
  • 132
  • 133
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley